TRIM50 and hepatocellular carcinoma: To explore whether expression of TRIM50 in HCC tissues was altered during the development of liver cancer, we detect the levels of TRIM50 in HCC tissues and corresponding non-cancerous liver tissues by immunohistochemistry (IHC), quantitative real-time polymerase chain reaction (qRT-PCR), and western blot.